<DOC>
	<DOCNO>NCT01986322</DOCNO>
	<brief_summary>The main objective study evaluate protectivity safety DTP/HB/Hib ( Bio Farma ) vaccine compare DTP/HB Hib vaccine give simultaneously .</brief_summary>
	<brief_title>Immunogenicity Safety DTP/HB/Hib ( Bio Farma ) Compared DTP/HB Given Simultaneously With Hib ( Registered ) Vaccine</brief_title>
	<detailed_description>This trial randomize , single blind , prospective intervention study . Total 220 subject ( 6-11 week age ) follow trial , divide 2 group , group consist 110 subject .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum phosphate</mesh_term>
	<criteria>Infant 611 week age Infant born 3742 week pregnancy Infant weigh 2.5 kg birth Father , mother legally acceptable representative properly inform study sign informed consent form Parents commit comply indication investigator schedule trial Mother least graduate elementary school Received Hepatitis B vaccine ( Bio Farma ) birth Child concomitantly enroll schedule enroll another trial Evolving moderate severe illness , especially infectious disease fever ( axillary temperature &gt; =37.5 Celsius Day 0 ) Known history allergy component vaccine component ( e.g.formaldehyde ) History uncontrolled coagulopathy blood disorder contraindicate intramuscular injection Known history congenital acquire immunodeficiency ( include HIV infection ) Child receive previous 4 week treatment likely alter immune response ( intravenous immunoglobulin , blood derive product long term corticotherapy ( &gt; 2 week ) Other vaccination within 7 day prior inclusion exception BCG poliomyelitis Any abnormality chronic disease accord investigator might interfere assessment trial objective Infant know history diphteria , tetanus , pertussis , Hib , Hepatitis B infection</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>11 Weeks</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>DTP/HB/Hib vaccine</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Infants</keyword>
	<keyword>Safety</keyword>
</DOC>